The genetics of psoriasis and autoimmunity

Annual Review of Genomics and Human Genetics

Volumn 6, Issue , 2005, Pages 93-122

  Bowcock, Anne M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Association; Autoimmune disease; Linkage; Tolerance

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR RUNX3;

ALLELE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL MATURATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CYTOKINE PRODUCTION; ENVIRONMENTAL FACTOR; FAMILIAL DISEASE; GENE CONTROL; GENE EXPRESSION; GENE LOCATION; GENE LOCUS; GENE SILENCING; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEMATOPOIETIC CELL; HUMAN; INFLAMMATORY DISEASE; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MONOZYGOTIC TWINS; PENETRANCE; PSORIASIS; REVIEW; T LYMPHOCYTE ACTIVATION; THYMUS;

ANTIGENS, CD4; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; BINDING SITES; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 17; CORE BINDING FACTOR ALPHA SUBUNITS; DERMATITIS, ATOPIC; ENVIRONMENT; GENE SILENCING; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; MODELS, GENETIC; MODELS, IMMUNOLOGICAL; MUTATION; PHENOTYPE; PSORIASIS;

EID: 25844505509     PISSN: 15278204     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.genom.6.080604.162324     Document Type: Review

References (138)

1. Allen M, Barker JWN, Bowcock AM, Burden AD, Chia N, et al. 2003. The International Psoriasis Genetics Study: assessing linkage to 14 candidate susceptibility loci in a cohort of 942 affected sib pairs. Am. J. Hum. Genet. 73:430-37
2. Adebajo AO. 1997. Low frequency of autoimmune disease in tropical Africa [comment]. Lancet 349:361-62
3. Aho K, Heliovaara M. 2004. Risk factors for rheumatoid arthritis. Ann. Med. 36:242-51
4. Akerblom HK, Vaarala O, Hyoty H, Ilonen J, Knip M. 2002. Environmental factors in the etiology of type 1 diabetes. Am. J. Med. Genet. 115:18-29
5. Alarcon-Riquelme ME, Prokunina L. 2003. Finding genes for SLE: complex interactions and complex populations. J. Autoimmun. 21:117-20
6. Alkhateeb A, Fain PR, Thody A, Bennett DC, Spritz RA. 2003. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res. 16:208-14
7. Alkhateeb A, Stetler GL, Old W, Talbert J, Uhlhorn C, et al. 2002. Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome Ip31.3-p32.2. Hum. Mol. Genet. 11:661-67
8. Allen M, Ishida-Yamamoto A, McGrath J, Davison S, Iizuka H, et al. 2001. Corneodesmosin expression in psoriasis vulgaris differs from normal skin and other inflammatory skin disorders. Lab. Invest. 81:969-76
9. Allen MH, Veal C, Faassen A, Powis SH, Vaughan RW, et al. 1999. A non-HLA gene within the MHC in psoriasis. Lancet 353:1589-90
10. Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, et al. 2003. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N. Engl. J. Med. 349:1526-33
11. Asumalahti K, Laitinen T, Itkonen-Vatjus R, Lokki ML, Suomela S, et al. 2000. A candidate gene for psoriasis near HLA-C, HCR (Pg8), is highly polymorphic with a disease-associated susceptibility allele. Hum. Mol. Genet. 9:1533-42
12. Asumalahti K, Veal C, Laitinen T, Suomela S, Allen M, et al. 2002. Coding haplotype analysis supports HCR as the putative susceptibility gene for psoriasis at the MHC PSORS1 locus. Hum. Mol. Genet. 11:589-97
13. Bamshad MJ, Mummidi S, Gonzalez E, Ahuja SS, Dunn DM, et al. 2002. A strong signature of balancing selection in the 5′ cis-regulatory region of CCR5. Proc. Natl. Acad. Sci. USA 99:10539-44
14. Ban Y, Tozaki T, Taniyama M, Tomita M, Ban Y. 2004. Association of a thyroglobulin gene polymorphism with Hashimoto's thyroiditis in the Japanese population. Clin. Endocrinol. (Oxford) 61:263-68
15. Barton A, Bowes J, Eyre S, Spreckley K, Hinks A, et al. 2004. A functional haplotype of the PADI4 gene associated with rheumatoid arthritis in a Japanese population is not associated in a United Kingdom population. Arthritis Rheum. 50:1117-21
16. Bassuny WM, Ihara K, Sasaki Y, Kuromaru R, Kohno H, et al. 2003. A functional polymorphism in the promoter/enhancer region of the FOXP3/Scurfin gene associated with type 1 diabetes. Immunogenetics 55:149-56
17. Becker KG, Simon RM, Bailey-Wilson JE, Freidlin B, Biddison WE, et al. 1998. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc. Natl. Acad. Sci. USA 95:9979-84
18. Begovich AB, Carlton VE, Honigberg LA, Schrodi SJ, Chokkalingam AP, et al. 2004. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am. J. Hum. Genet. 75:330-37
19. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, et al. 2001. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27:20-21
20. Bhalerao J, Bowcock AM. 1998. The genetics of psoriasis-a complex disorder of the skin and immune system. Hum. Mol. Genet. 7:1537-45
21. Bjorses P, Aaltonen J, Horelli-Kuitunen N, Yaspo M-L, Peltonen L. 1998. Gene defect behind APECED: a new clue to autoimmunity. Hum. Mol. Genet. 7:1547-53
22. Borgiani P, Vallo L, D'Apice MR, Giardina E, Pucci S, et al. 2002. Exclusion of CARD15/NOD2 as a candidate susceptibility gene to psoriasis in the Italian population. Eur. J. Dermatol. 12:540-42
23. Bottini N, Musumeci L, Alonso A, Rahmouni S, Nika K, et al. 2004. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat. Genet. 36:337-38
24. Bouma G, Strober W. 2003. The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. Immunol. 3:521-33
25. Bowcock AM, Cookson WO. 2004. The genetics of psoriasis, psoriatic arthritis and atopic dermatitis. Hum. Mol. Genet. 13(1):R43-55
26. Brenner O, Levanon D, Negreanu V, Golubkov O, Fainaru O, et al. 2004. Loss of Runx3 function in leukocytes is associated with spontaneously developed colitis and gastric mucosal hyperplasia. Proc. Natl. Acad. Sci. USA 101:16016-21
27. Buckley RH. 2003. Transplantation immunology: organ and bone marrow. J. Allergy Clin. Immunol. 111:8733-44
28. Bullard DC, Scharffetter-Kochanek K, McArthur MJ, Chosay JG, McBride ME, et al. 1996. A polygenic mouse model of psoriasiform skin disease in CD18-deficient mice. Proc. Natl. Acad. Sci. USA 93:2116-21
29. Cameron AL, Kirby B, Fei W, Griffiths CE. 2002. Natural killer and natural killer-T cells in psoriasis. Arch. Dermatol. Res. 294:363-69
30. Capon F, Allen MH, Ameen M, Burden AD, Tillman D, et al. 2004. A synonymous SNP of the corneodesmosin gene leads to increased mRNA stability and demonstrates association with psoriasis across diverse ethnic groups. Hum. Mol. Genet. 13:2361-68
31. Capon F, Helms C, Veal CD, Tillman D, Burden AD, et al. 2004. Genetic analysis of PSORS2 markers in a UK dataset supports the association between RAPTOR SNPs and familial psoriasis. J. Med. Genet. 41:459-60
32. Capon F, Munro M, Barker J, Trembath R. 2002. Searching for the major histocompatibility complex psoriasis susceptibility gene. J. Invest. Dermatol. 118:745-51
33. Chabas D, Taheri S, Renier C, Mignot E. 2003. The genetics of narcolepsy. Annu. Rev. Genomics Hum. Genet. 4:459-83
34. Chatila TA, Blaeser F, Ho N, Lederman HM, Voulgaropoulos C, et al. 2000. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome [see comment]. J. Clin. Invest. 106:R75-81
35. Coffman JA. 2003. Runx transcription factors and the developmental balance between cell proliferation and differentiation. Cell Biol. Intl. 27:315-24
36. Collado-Mesa F, Barcelo A, Arheart KL, Messiah SE. 2004. An ecological analysis of childhood-onset type 1 diabetes incidence and prevalence in Latin America [Analisis ecologico de la incidencia y prevalencia en America Latina de diabetes tipo I con inicio en la ninez]. Rev. Panam. Salud. Publica. 15:388-94
37. Consortium TF-GA. 1997. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat. Genet. 17:399-403
38. Cookson WO, Ubhi B, Lawrence R, Abecasis GR, Walley AJ, et al. 2001. Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci. Nat. Genet. 27:372-73
39. Danese S, Sans M, Fiocchi C. 2004. Inflammatory bowel disease: the role of environmental factors. Autoimmun. Rev. 3:394-400
40. Davies JL, Kawaguchi Y, Bennett ST, Copeman JB, Cordell HJ, et al. 1994. A genome-wide search for human type 1 diabetes susceptibility genes. Nature 371:130-36
41. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, et al. 1996. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia growth and development study, multicenter AIDS cohort study, multicenter hemophilia cohort study, San Francisco city cohort, ALIVE study. Science 273:1856-62
42. Duffy DL, Spelman LS, Martin NG. 1993. Psoriasis in Australian twins. J. Am. Acad. Dermatol. 29:428-34
43. Ebringer A, Wilson C. 2000. HLA molecules, bacteria and autoimmunity. J. Med. Microbiol. 49:305-11
44. Eisenberg R. 2003. Mechanisms of autoimmunity. Immunol. Res. 27:203-18
45. Elder JT, Nair RP, Voorhees JJ. 1994. Epidemiology and the genetics of psoriasis. J. Invest. Dermatol. 102:24S-27S
46. Elomaa O, Majuri I, Suomela S, Asumalahti K, Jiao H, et al. 2004. Transgenic mouse models support HCR as an effector gene in the PSORS1 locus. Hum. Mol. Genet. 13:1551-61
47. Fainaru O, Woolf E, Lotem J, Yarmus M, Brenner O, et al. 2004. Runx3 regulates mouse TGF-beta-mediated dendritic cell function and its absence results in airway inflammation. EMBO J. 23:969-79
48. Farber EM, Nail ML, Watson W. 1974. Natural history of psoriasis in 61 twin pairs. Arch. Dermatol. 109:207-11
49. Gaffney PM, Kearns GM, Shark KB, Ortmann WA, Selby SA, et al. 1998. A genome-wide search for susceptibility genes in'human systemic lupus erythematosus sib-pair families. Proc. Natl. Acad. Sci. USA 95:14875-79
50. Gaffney PM, Moser KL, Graham RR, Behrens TW. 2002. Recent advances in the genetics of systemic lupus erythematosus. Rheum. Dis. Clin. N.A. 28:111-26
51. Giardina E, Novelli G, Costanzo A, Nistico S, Bulli C, et al. 2004. Psoriatic arthritis and CARD15 gene polymorphisms: no evidence for association in the Italian population. J. Invest. Dermatol. 122:1106-7
52. Girardin SE, Boneca IG, Carneiro LA, Antignac A, Jehanno M, et al. 2003. Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 300:1584-87
53. Gottlieb AB, Krueger JG, Khandke L, Grossman RM, Krane J, Carter DM. 1991. Role of T cell activation in the pathogenesis of psoriasis. Ann. N. Y. Acad. Sci. 636:377-79
54. Guerrin M, Vincent C, Simon M, Tazi Ahnini R, Fort M, Serre G. 2001. Identification of six novel polymorphisms in the human corneodesmosin gene. Tissue Antigens 57:32-38
55. Guo D, Li M, Zhang Y, Yang P, Eckenrode S, et al. 2004. A functional variant of SUMO4, a new IkappaBalpha modifier, is associated with type 1 diabetes. Nat. Genet. 36:837-41
56. Hampe J, Frenzel H, Mirza MM, Croucher PJ, Cuthbert A, et al. 2002. Evidence for a NOD2-independent susceptibility locus for inflammatory bowel disease on chromosome 16p. Proc. Natl. Acad. Sci. USA 99:321-26
57. Harton JA, Linhoff MW, Zhang J, Ting JP. 2002. Cutting edge: CATERPILLER: a large family of mammalian genes containing CARD, pyrin, nucleotide-binding, and leucine-rich repeat domains. J. Immunol. 169:4088-93
58. Hebert SC, Mount DB, Gamba G. 2004. Molecular physiology of cation-coupled Cl- cotransport: the SLC12 family. Pflugers Arch. 447:580-93
59. Helms C, Cao L, Krueger JG, Wijsman EM, Chamian F, et al. 2003. A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis [see comment]. Nat. Genet. 35:349-56
60. Hewett D, Samuelsson L, Polding J, Enlund F, Smart D, et al. 2002. Identification of a psoriasis susceptibility candidate gene by linkage disequilibrium mapping with a localized single nucleotide polymorphism map. Genomics 79:305-14
61. Hori S, Nomura T, Sakaguchi S. 2003. Control of regulatory T cell development by the transcription factor Foxp3 [see comment]. Science 299:1057-61
62. Horrocks C, Holder JE, Berth-Jones J, Camp RD. 1997. Antigen-independent expansion of T cells from psoriatic skin lesions: phenotypic characterization and antigen reactivity. Br. J. Dermatol. 137:331-38
63. Hughes AL, Yeager M. 1998. Natural selection at major histocompatibility complex loci of vertebrates. Annu. Rev. Genet. 32:415-35
64. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, et al. 2001. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411:599-603
65. Hull KM, Shoham N, Chae JJ, Aksentijevich I, Kastner DL. 2003. The expanding spectrum of systemic autoinflammatory disorders and their rheumatic manifestations. Curr. Opin. Rheumatol. 15:61-69
66. Itoh K, Sakakibara M, Yamasaki S, Takeuchi A, Arase H, et al. 2002. Cutting edge: negative regulation of immune synapse formation by anchoring lipid raft to cytoskeleton through Cbp-EBP50-ERM assembly. J. Immunol. 168:541-44
67. Jacobson DL, Gange SJ, Rose NR, Graham NM. 1997. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin. Immunol. Immunopathol. 84:223-43
68. Jawaheer D, Seldin MF, Amos CI, Chen WV, Shigeta R, et al. 2003. Screening the genome for rheumatoid arthritis susceptibility genes: a replication study and combined analysis of 512 multicase families. Arthritis Rheum. 48:906-16
69. Jawaheer D, Seldin MF, Amos CI, Chen WV, Shigeta R, et al. 2003. Screening the genome for rheumatoid arthritis susceptibility genes: a replication study and combined analysis of 512 multicase families. Arthritis Rhuem. 48:906-16
70. Jonca N, Guerrin M, Hadjiolova K, Caubet C, Gallinaro H, et al. 2002. Corneodesmosin, a component of epidermal corneocyte desmosomes, displays homophilic adhesive properties. J. Biol. Chem. 277:5024-29
71. Jones DA, Yawalkar N, Suh KY, Sadat S, Rich B, Kupper TS. 2004. Identification of autoantigens in psoriatic plaques using expression cloning. J. Invest. Dermatol. 123:93-100
72. Karason A, Gudjonsson JE, Upmanyu R, Antonsdottir AA, Hauksson VB, et al. 2003. A susceptibility gene for psoriatic arthritis maps to chromosome 16q: evidence for imprinting. Am. J. Hum. Genet. 72:125-31
73. Kyogoku C, Langefeld CD, Ortmann WA, Lee A, Selby S, et al. 2004. Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am. J. Hum. Genet. 75:504-7
74. Lacaud G, Gore L, Kennedy M, Kouskoff V, Kingsley P, et al. 2002. Runx1 is essential for hematopoietic commitment at the hemangioblast stage of development in vitro. Blood 100:458-66
75. Lambert N, Nelson JL. 2003. Microchimerism in autoimmune disease: more questions than answers? Autoimmun. Rev. 2:133-39
76. Lee YA, Ruschendorf F, Windemuth C, Schmitt-Egenolf M, Stadelmann A, et al. 2000. Genomewide scan in German families reveals evidence for a novel psoriasis-susceptibility locus on chromosome 19p13. Am. J. Hum. Genet. 67:1020-24
77. Low JH, Williams FA, Yang X, Cullen S, Colley J, et al. 2004. Inflammatory bowel disease is linked to 19p13 and associated with ICAM-1. Inflamm. Bowel Dis. 10:173-81
78. Mallon E, Bunker CB. 2000. HIV-associated psoriasis. AIDS Patient Care Stud. 14:239-46
79. Marshall SE. 2004. Behcet's disease. Best Pract. Res. Clin. Rheumatol. 18:291-311
80. Menter A. 1998. Pathogenesis and genetics of psoriasis. Cutis 61:8-10
81. Morton NE, Collins A. 2002. Toward positional cloning with SNPs. Curr. Opin. Mol. Ther. 4:259-64
82. Nair RP, Henseler T, Jenisch S, Stuart P, Bichakjian CK, et al. 1997. Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan. Hum. Mol. Genet. 6:1349-56
83. 82a. Natl. Psoriasis Found. Bull. 2002. Psoriatic arthritis more common than suspected. 33:6
84. Nejentsev S, Guja C, McCormack R, Cooper J, Howson JM, et al. 2003. Association of intercellular adhesion molecule-1 gene with type 1 diabetes. Lancet 362:1723-24
85. Nejentsev S, Guja C, McCormack R, Cooper J, Howson JM, et al. 2003. Association of intercellular adhesion molecule-1 gene with type 1 diabetes. Lancet 362:1723-24
86. Neuhausen SL, Feolo M, Camp NJ, Farnham J, Book L, Zone JJ. 2002. Genome-wide linkage analysis for celiac disease in North American families. Am. J. Med. Genet. 111:1-9
87. Nickoloff BJ, Schroder JM, von den Driesch P, Raychaudhuri SP, Farber EM, et al. 2000. Is psoriasis a T-cell disease? Exp. Dermatol. 9:359-75
88. Nickoloff BJ, Wrone-Smith T. 1998. Superantigens, autoantigens, and pathogenic T cells in psoriasis. J. Invest. Dermatol. 110:459-60
89. Nieves DS, Phipps RP, Pollock SJ, Ochs HD, Zhu Q, et al. 2004. Dermatologic and immunologic findings in the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. Arch. Dermatol. 140:466-72
90. Nishimura H, Nose M, Hiai H, Minato N, Honjo T. 1999. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 11:141-51
91. Obermayer-Straub P, Strassburg CP, Manns MP. 2000. Autoimmune hepatitis. J. Hepatol. 32:181-97
92. Ockenfels HM. 2003. Trigger factors for psoriasis. Hautarzt 54:215-23
93. Oksenberg JR, Seboun E, Hauser SL. 1996. Genetics of demyelinating diseases. Brain Pathol. 6:289-302
94. Olsen JV, Skov L, Baadsgaard O. 1999. Superantigens and their importance for inflammatory skin diseases. Ugeskrift for Laeger 161:4747-50
95. Onengut-Gumuscu S, Ewens KG, Spielman RS, Concannon P. 2004. A functional polymorphism (1858C/T) in the PTPN22 gene is linked and associated with type I diabetes in multiplex families. Genes Immun. 5:678-80
96. Osato M, Yanagida M, Shigesada K, Ito Y. 2001. Point mutations of the RUNx1/AML1 gene in sporadic and familial myeloid leukemias. Int. J. Hematol. 74:245-51
97. Padyukov L, Silva C, Stolt P, Alfredsson L, Klareskog L. 2004. A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. Arthritis Rheum. 50:3085-92
98. Peltekova VD, Wintle RF, Rubin LA, Amos CI, Huang Q, et al. 2004. Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat. Genet. 36:471-75
99. Pericak-Vance MA, Rimmler JB, Martin ER, Haines JL, Garcia ME, et al. 2001. Linkage and association analysis of chromosome 19q13 in multiple sclerosis. Neurogenetics 3:195-201
100. Plant D, Lear J, Marsland A, Worthington J, Griffiths CE. 2004. CARD15/NOD2 single nucleotide polymorphisms do not confer susceptibility to type I psoriasis. Br. J. Dermatol. 151:675-78
101. Prinz JC. 2003. The role of T cells in psoriasis. J. Eur. Acad. Dermatol. Venereol. 17:257-70
102. Prokunina L, Castillejo-Lopez C, Oberg F, Gunnarsson I, Berg L, et al. 2002. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat. Genet. 32:666-69
103. Prokunina L, Padyukov L, Bennet A, de Faire U, Wiman B, et al. 2004. Association of the PD-1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope. Arthritis Rheum. 50:1770-73
104. Rahman P, Bartlett S, Siannis F, Pellett FJ, Farewell VT, et al. 2003. CARD15: a pleiotropic autoimmune gene that confers susceptibility to psoriatic arthritis. Am. J. Hum. Genet. 73:677-81
105. Rahman P, Bartlett S, Siannis F, Pellett FJ, Farewell VT, et al. 2003. CARD15: a pleiotropic autoimmune gene that confers susceptibility to psoriatic arthritis. Am. J. Hum. Genet. 73:677-81
106. Reczek D, Berryman M, Bretscher A. 1997. Identification of EBP50: A PDZ-containing phosphoprotein that associates with members of the ezrin-radixin-moesin family. J. Cell. Biol. 139:169-79
107. Reveille JD. 2004. The genetic basis of spondyloarthritis. Curr. Rheumatol. Rep. 6:117-25
108. Rioux JD, Daly MJ, Silverberg MS, Lindblad K, Steinhart H, et al. 2001. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat. Genet. 29:223-28
109. Rosen P, Hopkin RJ, Glass DN, Graham TB. 2004. Another patient with chromosome 18 deletion syndrome and juvenile rheumatoid arthritis. J. Rheumatol. 31:998-1000
110. Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, et al. 1996. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382:722-25
111. Shoham NG, Centola M, Mansfield E, Hull KM, Wood G, et al. 2003. Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway. Proc. Natl. Acad. Sci. USA 100:13501-6
112. Silman AJ, Pearson JE. 2002. Epidemiology and genetics of rheumatoid arthritis. Arthritis Res. 4:5265-72
113. Simon M, Jonca N, Guerrin M, Haftek M, Bernard D, et al. 2001. Refined characterization of corneodesmosin proteolysis during terminal differentiation of human epidermis and its relationship to desquamation. J. Biol. Chem. 276:20292-99
114. Song WJ, Sullivan MG, Legare RD, Hutchings S, Tan X, et al. 1999. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat. Genet. 23:166-75
115. Stoll M, Corneliussen B, Costello CM, Waetzig GH, Mellgard B, et al. 2004. Genetic variation in DLG5 is associated with inflammatory bowel disease. Nat. Genet. 36:476-80
116. Taniuchi I, Littman DR. 2004. Epigenetic gene silencing by Runx proteins. Oncogene 23:4341-45
117. Taniuchi I, Osato M, Egawa T, Sunshine MJ, Bae SC, et al. 2002. Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. Cell 111:621-33
118. Tazi Ahnini R, Camp NJ, Cork MJ, Mee JB, Keohane SG, et al. 1999. Novel genetic association between the corneodesmosin (MHC S) gene and susceptibility to psoriasis. Hum. Mol. Genet. 8:1135-40
119. Tein I. 2003. Carnitine transport: pathophysiology and metabolism of known molecular defects. J. Inherit. Metab. Dis. 26:147-69
120. Tiilikainen A, Lassus A, Karvonen J, Vartiainen P, Julin M. 1980. Psoriasis and HLA-Cw6. Br. J. Dermatol. 102:179-84
121. Tokuhiro S, Yamada R, Chang X, Suzuki A, Kochi Y, et al. 2003. An intronic SNP in a RUNX1 binding.site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis [see comment]. Nat. Genet. 35:341-48
122. Tomfohrde J, Silverman A, Barnes R, Fernandez-Vina M, Young M, et al. 1994. Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. Science 264:1141-45
123. Trembath RC, Clough RL, Rosbotham JL, Jones AB, Camp RD, et al. 1997. Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis. Hum. Mol. Genet. 6:813-20
124. Ueda H, Howson JM, Esposito L, Reward J, Snook H, et al. 2003. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423:506-11
125. van Heel DA, Fisher SA, Kirby A, Daly MJ, Rioux JD, Lewis CM. 2004. Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairs. Hum. Mol. Genet. 13:763-70
126. Vandiedonck C, Beaurain G, Giraud M, Hue-Beauvais C, Eymard B, et al. 2004. Pleiotropic effects of the 8.1 HLA haplotype in patients with autoimmune myasthenia gravis and thymus hyperplasia. Proc. Natl. Acad. Sci. USA 101:15464-69
127. Velaga MR, Wilson V, Jennings CE, Owen CJ, Herington S, et al. 2004. The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease. J Clin. Endocrinol. Metab. 89:5862-65
128. Villanueva R, Greenberg DA, Davies TF, Tomer Y. 2003. Sibling recurrence risk in autoimmune thyroid disease. Thyroid 13:761-64
129. Vossenaar ER, van Venrooij WJ. 2004. Citrullinated proteins: sparks that may ignite the fire in rheumatoid arthritis. Arthritis Res. Ther. 6:107-11
130. Vyse TJ, Todd JA. 1996. Genetic analysis of autoimmune disease. Cell 85:311-18
131. Waltzer L, Ferjoux G, Bataille L, Haenlin M. 2003. Cooperation between the GATA and RUNX factors Serpent and Lozenge during Drosophila hematopoiesis. EMBO J. 22:6516-25
132. Watanabe T, Kitani A, Murray PJ, Strober W. 2004. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat. Immunol. 5:800-8
133. Weiss G, Shemer A, Trau H. 2002. The Koebner phenomenon: review of the literature. J. Eur. Acad. Dermatol. Venereol. 16:241-48
134. Wise CA, Gillum JD, Seidman CE, Lindor NM, Veile R, et al. 2002. Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder. Hum. Mol. Genet. 11:961-69
135. Wong FS, Wen L. 2003. The study of HLA class II and autoimmune diabetes. Curr. Mol. Med. 3:1-15
136. Woolf E, Xiao C, Fainaru O, Lotem J, Rosen D, et al. 2003. Runx3 and Runx1 are required for CD8 T cell development during thymopoiesis. Proc. Natl. Acad. Sci. USA 100:7731-36
137. Yamada R, Suzuki A, Chang X, Yamamoto K. 2003. Peptidylarginine deiminase type 4: identification of a rheumatoid arthritis-susceptible gene. Trends Mol. Med. 9:503-8
138. Yip SP, Leung KH, Lin CK. 2003. Extent and distribution of linkage disequilibrium around the SLC11A1 locus. Genes Immun. 4:212-21